Baudouin A. Standaert

Diepenbeek, VLG 3590, Belgium

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 61 publications

Proposed Conceptual and Experience-Based Framework for Reaching an Optimal Vaccine Launch Strategy.

Proposed Conceptual and Experience-Based Framework for Reaching an Optimal Vaccine Launch Strategy.

Journal: Vaccines
Published: March 30, 2026

Vaccine Development, Its Implementation and Price Setting: A Historical Perspective with Proposed Ways to Move Forward.

Vaccine Development, Its Implementation and Price Setting: A Historical Perspective with Proposed Ways to Move Forward.

Journal: Journal of market access & health policy
Published: June 12, 2025

Measuring the Vaccine Success Index: A Framework for Long-Term Economic Evaluation and Monitoring in the Case of Rotavirus Vaccination.

Measuring the Vaccine Success Index: A Framework for Long-Term Economic Evaluation and Monitoring in the Case of Rotavirus Vaccination.

Journal: Vaccines
Published: October 09, 2024

The Knowledge and Application of Economics in Healthcare in a High-Income Country Today: The Case of Belgium.

The Knowledge and Application of Economics in Healthcare in a High-Income Country Today: The Case of Belgium.

Journal: Journal of market access & health policy
Published: June 01, 2024

Discounting health gain: a different view.

Discounting health gain: a different view.

Journal: Journal of market access & health policy
Published: November 08, 2023

Comment on Postma et al. Predicted Public Health and Economic Impact of Respiratory Syncytial Virus Vaccination with Variable Duration of Protection for Adults ≥60 Years in Belgium. Vaccines 2023, 11, 990.

Comment on Postma et al. Predicted Public Health and Economic Impact of Respiratory Syncytial Virus Vaccination with Variable Duration of Protection for Adults ≥60 Years in Belgium. Vaccines 2023, 11, 990.

Journal: Vaccines
Published: July 06, 2023

The Economic Value of Rotavirus Vaccination When Optimally Implemented in a High-Income Country.

The Economic Value of Rotavirus Vaccination When Optimally Implemented in a High-Income Country.

Journal: Vaccines
Published: January 24, 2023

Identification of an Optimal COVID-19 Booster Allocation Strategy to Minimize Hospital Bed-Days with a Fixed Healthcare Budget.

Identification of an Optimal COVID-19 Booster Allocation Strategy to Minimize Hospital Bed-Days with a Fixed Healthcare Budget.

Journal: Vaccines
Published: December 21, 2022

Estimated public health impact of human rotavirus vaccine (HRV) and pneumococcal polysaccharide protein D-conjugate vaccine (PHiD-CV) on child morbidity and mortality in Gavi-supported countries.

Estimated public health impact of human rotavirus vaccine (HRV) and pneumococcal polysaccharide protein D-conjugate vaccine (PHiD-CV) on child morbidity and mortality in Gavi-supported countries.

Journal: Human vaccines & immunotherapeutics
Published: December 12, 2022

Infections and hospital bed-days among aging adults: A five-year retrospective study in a Belgian general hospital.

Infections and hospital bed-days among aging adults: A five-year retrospective study in a Belgian general hospital.

Journal: Frontiers in medical technology
Published: April 04, 2022

Defining the Recipe for an Optimal Rotavirus Vaccine Introduction in a High-Income Country in Europe.

Defining the Recipe for an Optimal Rotavirus Vaccine Introduction in a High-Income Country in Europe.

Journal: Viruses
Published: December 07, 2021

Explaining the formation of a plateau in rotavirus vaccine impact on rotavirus hospitalisations in Belgium.

Explaining the formation of a plateau in rotavirus vaccine impact on rotavirus hospitalisations in Belgium.

Journal: Vaccine
Published: September 30, 2021
Showing 1-12 of 61

Last Updated: 09/26/2026